Palatin Technologies
PTN
#9923
Rank
S$50.74 M
Marketcap
S$29.81
Share price
4.59%
Change (1 day)
2,294.32%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -S$22.66 Million

According to Palatin Technologies's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$34.91 Million, an increase over its 2023 earnings that were of -S$42.01 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$22.66 Million-35.11%
2024 -S$34.91 Million-16.9%
2023 -S$42.01 Million5.99%
2022 -S$39.64 Million-13.7%
2021 -S$45.93 Million33.25%
2020 -S$34.47 Million-172.11%
2019 S$47.79 M2352.33%
2018 S$1.94 M-94.13%
2017 S$33.21 M-154.92%
2016 -S$60.47 Million3.67%
2015 -S$58.33 Million878%
2014 -S$5.97 Million-72.64%
2013 -S$21.8 Million-33.11%
2012 -S$32.59 Million77.71%
2011 -S$18.34 Million
2003 -S$31.06 Million29.93%
2002 -S$23.9 Million36.18%
2001 -S$17.55 Million
1999 -S$14.57 Million6.04%
1998 -S$13.74 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
MediciNova
MNOV
-S$15.31 Million-31.72%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-S$38.22 Million 70.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$0.75 B-3,472.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
S$65.5 M-392.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$86.55 M-486.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-S$0.16 Billion 580.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$41.98 B-187,443.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-S$71.99 Million 221.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$16.96 B-75,798.43%๐Ÿ‡ฌ๐Ÿ‡ง UK